Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXH7XA
|
||||
| Drug Name |
(S)-1-(2-Methyl-1H-indol-4-yloxy)-3-[(2S,4R)-2-methyl-4-(4-methyl-benzo[b]thiophen-2-yl)-piperidin-1-yl]-propan-2-ol
|
||||
| Synonyms |
CHEMBL131370
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H32N2O2S
|
||||
| Canonical SMILES |
C[C@H]1C[C@@H](CCN1C[C@H](O)COc2cccc3[nH]c(C)cc23)c4cc5c(C)cccc5s4
|
||||
| InChI |
InChI=1S/C27H32N2O2S/c1-17-6-4-9-26-22(17)14-27(32-26)20-10-11-29(19(3)13-20)15-21(30)16-31-25-8-5-7-24-23(25)12-18(2)28-24/h4-9,12,14,19-21,28,30H,10-11,13,15-16H2,1-3H3/t19-,20+,21-/m0/s1
|
||||
| InChIKey |
ZRZHPXBPYCNVBE-HBMCJLEFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.